{{chembox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 460036705
| ImageFile = Cilazapril structure.svg
| ImageFile_Ref = {{chemboximage|correct|??}}
| ImageSize = 222
| ImageName = Kekulé, stereo, skeletal formula of cilazapril ((1S,9S)-9-[(2S)-2-yl]amin,-1-carbox)
| IUPACName = (4''S'',7''S'')-7-<nowiki>[[</nowiki>(2''S'')-1-Ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-6-oxo-1,2,3,4,7,8,9,10-octahydropyridazino[1,2-a]diazepine-4-carboxylic acid
| SystematicName = 

|Section1 = {{Chembox Identifiers
| IUPHAR_ligand = 6459
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 8Q9454114Q
| CASNo_Ref = {{cascite|changed|CAS}}
| CASNo = 88768-40-5
| PubChem = 56330
| PubChem1 = 40467985
| PubChem1_Comment = (1''R'',9''S'')-(2''S'')-butylamino isomer
| ChemSpiderID = 50831
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| KEGG = D07699
| KEGG_Ref = {{keggcite|correct|kegg}}
| ChEMBL = 515606
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01340
| SMILES = CCOC(=O)C(CCc1ccccc1)NC1CCCN2CCCC(N2C1=O)C(O)=O
| StdInChI = 1S/C22H31N3O5/c1-2-30-22(29)18(13-12-16-8-4-3-5-9-16)23-17-10-6-14-24-15-7-11-19(21(27)28)25(24)20(17)26/h3-5,8-9,17-19,23H,2,6-7,10-15H2,1H3,(H,27,28)
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = HHHKFGXWKKUNCY-UHFFFAOYSA-N
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
}}

|Section2 = {{Chembox Properties
| C=22 | H=31 | N=3 | O=5
| LogP = 2.212
| pKa = 2.285
| pKb = 11.712
}}

|Section6={{Chembox Pharmacology
| ATCCode_prefix = C09
| ATCCode_suffix = AA08
| AdminRoutes = Oral
| Legal_UK = POM
}}
}}

'''Cilazapril''' is an [[angiotensin-converting enzyme]] inhibitor ([[ACE inhibitor]]) used for the treatment of [[hypertension]] and [[congestive heart failure]].<ref>{{Cite journal 
| last1 = Szucs | first1 = T. 
| title = Cilazapril. A review 
| journal = Drugs 
| volume = 41 Suppl 1 
| pages = 18–24 
| year = 1991 
| pmid = 1712267
| doi=10.2165/00003495-199100411-00005
}}</ref><ref>{{cite book|title=Austria-Codex|editor=Jasek, W|publisher=Österreichischer Apothekerverlag|location=Vienna|year=2007|edition=2007/2008|isbn=978-3-85200-181-4|language=German}}</ref> It is branded as '''Dynorm''', '''Inhibace''', '''Vascace''' and many other names in various countries. None of these are available in the United States as of May 2010.<ref>"[http://www.drugs.com/international/cilazapril.html Cilazapril]". ''[[Drugs.com]]''. Retrieved 28 May 2010.</ref>

Of the eight possible [[stereoisomers]], only the all-(''S'')-form is medically viable.{{citation needed|date=February 2012}}

==References==
{{reflist}}

{{ACE inhibitors}}
{{Angiotensin receptor modulators}}

[[Category:ACE inhibitors]]
[[Category:Carboxylic acids]]
[[Category:Enantiopure drugs]]
[[Category:Ethyl esters]]
[[Category:Lactams]]
[[Category:Prodrugs]]
[[Category:Nitrogen heterocycles]]
[[Category:Heterocyclic compounds (2 rings)]]
[[Category:Butyrates]]

{{cardiovascular-drug-stub}}